Savings can be as high as 80%
What forms the bulk of the retail price2 of peptides is not the cost of manufacturing, but the capital infrastructure: the regulatory burden, the cold chain logistics, the pen device (which sometimes costs more than the drug itself), and, above all, the return needed to justify $9 billion in the initial R&D of these GLP-1 drugs
The Next Chapter of Addiction Treatment As science continues to uncover how GLP-1 receptor agonists interact with the brains reward circuits, new possibilities are emerging for treating compulsive and addictive behaviors
Patients who incorporate B12 + MIC injections into a structured wellness plan may notice improved energy levels and a reduction in fatigue, which can make it easier to maintain an active lifestyle
Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome
Inflammatory Bowel Diseases 2015;21:361368